Crossmark

Sorafenib-induced macrophage extracellular traps via ARHGDIG/IL4/PADI4 axis confer drug resistance through inhibiting ferroptosis in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1186/s13062-024-00560-4

Published Online: 2024-11-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Xiangbo

Yi, Nan

Zhu, Pengfei

Gao, Jian

Lv, Jun
Funding

Funding for this research was provided by:

Henan Medical Science and Technique Foundation (LHGJ20190221)

Science and Technology Commission of Shanghai Municipality (21YF1445300)

Henan Province Science and Technology Innovation Talent Program (JQRC2023015)
License Information

Text and Data Mining valid from 2024-11-11

Version of Record valid from 2024-11-11
More Information

Article History

Received: 27 June 2024

Accepted: 4 November 2024

First Online: 11 November 2024

Declarations

:

: The animal experiment in this study was approved by the Animal Care and Use Committee of the First Affiliated Hospital of Zhengzhou University.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below